According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
French Health Minister Olivier Veran has said that "200 to 300" new cases of Covid19 per day are believed to be carriers of the so-called British vari...
Read More
As the Principality continues its vaccination campaign Monaco’s Minister of State, Pierre Dartout, will be vaccinated today. Emails are to be sent tod...
Read More
A second college in the Alpes Maritimes has had to close due to Covid. Monday saw the Bellevue college in Beausoliel close its doors to students for a...
Read More